Our Latest News

Wed Mar 07 00:00:00 EST 2018

The ACTIS® Total Hip System from DePuy Synthes is Designed to Improve Initial Implant Stability in Total Hip Replacement

MARCH 7, 2018 New Orleans, LA – DePuy Synthes*, part of the Johnson & Johnson Medical Devices Companies**, today introduced the ACTIS® Total Hip System in the US at the 2018 American Academy of Orthopaedic Surgeons (AAOS) Annual Meeting in New Orleans, LA. Recently available on a limited basis, this is the first DePuy Synthes hip system designed to be utilized with tissue-sparing approaches such as the minimally invasive Anterior Approach, as well as traditional approaches in Total Hip Replacement (THR) surgery.

Tue Mar 06 00:00:00 EST 2018

New ATTUNE® Revision Knee System from DePuy Synthes Utilizes Proprietary Technologies to Address Broad Range of Complex Primary & Revision Procedures

MARCH 6, 2018 New Orleans, LA – DePuy Synthes*, part of the Johnson & Johnson Medical Devices Companies**, today announced the US launch of the ATTUNE® Revision Knee System, to complement the ATTUNE Primary Knee System and provide surgeons with a comprehensive solution for knee replacement. The ATTUNE Revision Knee System is being introduced at the 2018 American Academy of Orthopaedic Surgeons (AAOS) Annual Meeting in New Orleans, LA.

Mon Mar 05 00:00:00 EST 2018

DePuy Synthes Announces Agreement with SERF to Add Dual Mobility System to Its Leading Hip Portfolio

CORK, Ireland – March 5, 2018– DePuy Synthes, the orthopaedics business of Johnson & Johnson Medical Devices Companies, plans to add a dual-mobility acetabular cup to its leading hip portfolio as a result of an agreement between DePuy Ireland Unlimited Company and SERF (Société d’Etude, de Recherche et de Fabrication). SERF is a French-based orthopaedics company that has a long and respected heritage in dual-mobility technology.

Tue Feb 20 00:00:00 EST 2018

Johnson & Johnson Medical Devices Companies Acquire Orthotaxy to Develop Next-Generation Robotic-Assisted Surgery Platform in Orthopaedics

PARIS – February 20, 2018 – Johnson & Johnson Medical Devices Companies, through French affiliate Apsis S.A.S., announced today the acquisition of Orthotaxy, a privately-held developer of software-enabled surgery technologies, including a differentiated robotic-assisted surgery solution. This proprietary technology is currently in early-stage development for total and partial knee replacement, and the Johnson & Johnson Medical Devices Companies plan to broaden its application for a range of orthopaedic surgery procedures.

Mon Jan 29 00:00:00 EST 2018

New Study on Total Hip Arthroplasty (THA) Outcomes with Anterior Approach Show Less Reported Pain, Fewer Narcotics & Better Hip Function in the First 90 Days

JANUARY 24, 2018 Warsaw, Indiana – DePuy Synthes*, part of the Johnson & Johnson Medical Devices Companies, today announced the first systematic review of prospective studies comparing postoperative outcomes through 90 days of Anterior Approach versus Posterior Approach in primary total hip arthroplasty (THA). The paper, published in The Journal of Arthroplasty, concludes that the Anterior Approach can provide a significant increase in hip function and reduction in pain and narcotics usage compared to Posterior Approach. In addition, the study showed no statistical differences in complication rates between the Anterior Approach and Posterior Approach through 90 days.

Wed Dec 13 00:00:00 EST 2017

DePuy Synthes Announces Financing Options for the Hana® Orthopedic Surgery Table

DECEMBER 13, 2017, Warsaw, Indiana – As an industry leader in the Anterior Approach, today DePuy Synthes*, part of the Johnson & Johnson Medical Devices Companies, announced a partnership with Johnson & Johnson Finance Corporation (JJFC) to help healthcare systems accommodate costs associated with the Hana® Orthopedic Surgery Table. The Hana® table allows precise control of patient positioning, manipulation and traction during this minimally invasive hip replacement surgery and provides better access to the hip joint for improved alignment and positioning of the implant.